Pomerantz LLP is investigating claims on behalf of investors of Nano-X Imaging Ltd. following the company's announcement of a $33.4 million net loss in Q4 2025, largely due to a $17.5 million impairment charge related to restructuring its Korean chip facility. The investigation also concerns the resignation of CFO Ran Daniel, effective July 31, 2026. After the announcement, Nano-X's stock price dropped 24.39%, signaling investor concern. The law firm is examining whether Nano-X and its officers engaged in securities fraud or other unlawful practices, which could impact shareholders and the company's future operations.
Roota, a plant-based topical hair and scalp care brand, offers a roll-on serum and activator spray formulated with rosemary oil, biotin, caffeine, peptides, Redensyl, and AnaGain. The products are designed for targeted application to support the appe...
Calidi Biotherapeutics announced that its 2025 Annual Report included an audit report with an explanatory paragraph highlighting the assumption that the company will continue as a going concern. This disclosure is mandated by the NYSE American Compan...
UraniumX Discovery Corp. has been approved for trading on the OTCQB Venture Market as of May 14, 2026, enhancing transparency and access for U.S. investors. This move supports the company's active phase, including a detailed geophysical survey and up...
Grayscale's latest report highlights Ethereum, Solana, BNB Chain, and Canton Network as the top blockchains likely to gain from the advancing Digital Asset Market Clarity Act in the US. This legislation aims to establish clear rules for digital asset...
OneMain Holdings (OMF) is rated a strong buy due to its conservative underwriting, strong reserves covering 242% of delinquencies, and stable employment trends that keep credit risk manageable despite inflation. The company expects loan growth of 6-9...
